Direct-acting oral anticoagulants in patients with atrial fibrillation and valvular heart disease.

Natalie Canales, Tina Cao,Neeloufar Fakourfar, Mara Snee,Laura Tsu

JAAPA : official journal of the American Academy of Physician Assistants（2022）

引用 0|浏览4

暂无评分

摘要

ABSTRACT:Direct-acting oral anticoagulants (DOACs) are an effective alternative to warfarin for patients with atrial fibrillation (AF) who require thromboembolic risk reduction. This article discusses the newly acceptable use of DOACs in patients with valvular AF, including native valvular heart disease and patients with bioprosthetic valves.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要